Toxicology - CVS Flashcards
(35 cards)
Management of severe calcium channel blocker overdose
IV fluid loading
Calcium gluconate 10%, 60 mls over 5-10 min, x3 Q20 min
Adrenaline infusion 1 mcg/kg/min (up to 60/70)
High dose Insulin Euglycaemic therapy (cardgiogenic shock)
Noradrenaline
Methylene blue (vasoplegic shock)
ECMO
How to administer high dose insulin euglycaemic therapy
50 mls of 50% glucose 1 unit / kg IV rapid acting insulin then infusion via CVC of 25g / hr glucose 0.5 units/kg/hr IV insulin, up to 1-2 u/kg/hr Replace potassium
Indications for digoxin fab fragments
Hyperkalaemia > 5 / 5.5
Ingestion of > 10g / 4g in child
Haemodynamically unstable / arrest
Serum digoxin concentration > 15 nmol/L
Dosing of digoxin fab fragments
1 ampoule = 40 mg 40-80 mg reasonable and reassess calc: dose (mg) x 0.8 x 2 unstable - 10 ampoules arrest - 20 ampoules
Benzodiazepine for sedation in setting of delirium
5mg IV diazepam every 5-10 min
Management of toxicological seizures
A/B/C
Check BSL
IV diazepam 5-10 min over 3-5 min
2nd line barbiturate (phenobarbitone 100-300 mg/kg slow IV (10-20 mg/kg)
3rd: pyridoxine if due to isoniazid or hydrazine 70mg/kg to 5g
Temperature threshold for intubation and active cooling in toxicological hyperthermia
39.5 deg
Name the receptors and side effect involved for various features of antipsychotic overdose
- Dopamine antagonist - muscle rigidity, bradykinsia, temperature regulation
- Muscarinic - delirium, tachycardia, urinary retention
- Histamine - sedation, hypotension
- Alpha adrenergic antagonist - vasodilation / hypotension
- Sodium channel blockade - wide QRS
Features of NMS
Altered mental status
Hyperthermia
Autonomic dysfunction
Muscle rigidity
Dose of quetiapine with significant symptoms expected and treatment
> 3g
Require intubation / ICU admission
IV fluids
Noradrenaline for hypotension (not adrenaline)
Discharge criteria for quetiapine overdose
< 3g, discharge at 4 hrs when well with normal ECG (or 8 hrs if XR) and not at night and psychiatric risk assessment completed.
SSRI antidepressant and threshold for seizures / long QT, change in management compared to other SSRI
Escitalopram 300mg
Citalopram 600 mg
Administer charcoal up to 4 hrs
Cardiac monitor to 8 hrs (12 if > 500/1000 mg) compared to 6 hrs.
Risk assessment in TCA overdose
> 10 mg/kg significant clinical toxicity
> 20/30 mg/kg: coma, hypotension, seizures and arrhythmias.
ECG changes and implication in TCA overdose
R wave > 3 mm, R/S ratio > 0.7 in aVR - seizures / arrhythmias
QRS width > 100 msec - seizures
QRS with > 160 msec - ventricular arrhythmias
Long QT - not predictive clinical toxicity
Management of TCA overdose
Secure airway (decrease consciousness, < GCS 12)
Hyperventilation
Sodium bicarbonate 8.4 %, 1-2 mEq/kg, to pH 7.5-7.55
Hypotension: IV fluid, noradrenaline
Resistant arrhythmia with pH >7.5, lignocaine 1.5 mg/kg IV
Indications for sodium bicarbonate in TCA overdose
Cardiovascular dysfunction
- QRS > 100 msec
- Hypotension unresponsive to fluid
- Any arrhythmia
Symptoms and management in acute lithium overdose
Nausea, vomiting, diarrhoea. Supportive care Correct sodium / water deficit Rarely particularly toxic Check level 6 hourly
Symptoms and mangement in chronic lithium toxicity
Neurological symptoms - tremor, hyperreflexia, agitation, ataxia –> stupor, rigidity, coma.
Worse if dehydration, hyponatraemia or renal failure.
Haemodialysis if level >4 with renal failure, severe symptoms, of [Li] > 5 mEq/L
4 phases of paracetamol toxicity
1: asymptomatic, N/V
2: 1-2 days - hepatotoxicity develops, RUQ pain and abnormal ALT/AST and INR
3: 3-4 days - fulminant liver failure, coagulopathy, metabolic acidosis, jaundice, encephalopathy, death.
4: recovery
Factors associated with higher risk in paracetamol overdose
Liver enzyme induction agents Liver impairment pre-existing Chronic alcohol ingestion Starvation / prolonged fasting Slow release preparations Massive ingestion (>500mg/kg, >30g, level > 450 mg/L) Multiple ingestions Unknown time of ingestion
Treatment of IR paracetamol, presenting < 8 hrs
Paracetamol level, commence NAC based on level. no further bloods unless high risk group.
Treatment of IR paracetamol presenting 8-24 hrs
Commence NAC.
Paracetamol level and LFTs.
Cease if paracetamol level < nomogram and normal LFTs, otherwise complete 20 hr course.
LFTs repeated at 18 hrs.
Further 100mg/kg/16 hrs if AST/ALT rising.
Treatment of IR paracetamol presenting > 24 hrs
Commence NAC
Prolonged therapy if LFTs rising at 18 hr bloods. Continue at 100 mg/kg/12 hrs until INR / LFTs normalising or transplant.
Treatment of IR paracetamol with unknown timeframe of ingestion
Commence NAC.
Stop at 20 hrs if LFTs normal and paracetamol negative.